Author

Muriel Lins

ORCID: 0009-0006-0989-4268

Observed ORCID: 0009-0006-0989-4268

OpenAlex ID: A5038241334

Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons

2024 · Michael G Ison, Alberto Papi, et al. · Clinical Infectious Diseases · 195

PDF

Efficacy and Safety of a Booster Regimen of Ad26.COV2.S Vaccine against Covid-19

2022 · Karin Hardt, An Vandebosch, et al. · The Lancet Infectious Diseases · 91

PDF

Assessment of Small Pulmonary Blood Vessels in COVID-19 Patients Using HRCT

2020 · Muriel Lins, Jan Vandevenne, et al. · Academic Radiology · 69

PDF

Respiratory Syncytial Virus Prefusion F Protein Vaccine Is Efficacious in Older Adults With Underlying Medical Conditions

2023 · Robert G Feldman, Raffaele Antonelli-Incalzi, et al. · Clinical Infectious Diseases · 67

PDF

Efficacy of oral 20-hydroxyecdysone (BIO101), a MAS receptor activator, in adults with severe COVID-19 (COVA): a randomized, placebo-controlled, phase 2/3 trial

2024 · Suzana Margareth Lobo, Gaétan Plantefève, et al. · EClinicalMedicine · 30

PDF

CT-derived measurements of pulmonary blood volume in small vessels and the need for supplemental oxygen in COVID-19 patients

2022 · Wendel Dierckx, Wilfried De Backer, et al. · Journal of Applied Physiology · 28

PDF

Immunogenicity and Safety of Co-administration of Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine With 20-Valent Pneumococcal Conjugate Vaccine in Adults Aged ≥60 Years: A Randomized, Non-inferiority Trial

2026 · Isabel Leroux-Roels, Muriel Lins, et al. · Clinical Infectious Diseases · 5

Rapid & sustained benefit of benralizumab in severe eosinophilic asthma: the BE-REAL study

2026 · Lieven Dupont, Charles Pilette, et al. · Respiratory Medicine · 2

Optimizing COPD Care in Belgium: A Multidisciplinary Expert Consensus on Cardiopulmonary Risk Management

2026 · Naomi Michotte, Fabian Demeure, et al. · International Journal of COPD · 1

PDF

A Phase 1/2 Trial Evaluating the Safety and Immunogenicity of an mRNA-based Seasonal Influenza Vaccine Candidate Encoding Hemagglutinin and Neuraminidase

2026 · Ilse De Coster, Jose F. Cardona, et al. · Infectious Diseases and Therapy

PDF

Mandibular Advancement Device Therapy in 182 DISE-Selected Adults with Moderate-to-Severe Obstructive Sleep Apnea: A Multicenter Real-World Study

2026 · Marc J. Braem, Muriel Lins, et al. · Biomedicines

Enhancing Clinical Remission and Reducing Health Care Utilization in Severe Eosinophilic Asthma: Real-World Benefits of Benralizumab in Belgium

2025 · Lieven Dupont, Charles Pilette, et al. · European Respiratory Journal

Efficacy of Oral 20-hydroxyecdysone (20E) in adults with severe COVID-19

2024 · Capucine Morelot-Panzini, Bryan Snyder, et al. · European Respiratory Journal

A Belgian real-world study indicates rapid and sustained asthma symptom control with benralizumab

2024 · Lieven Dupont, Charles Pilette, et al. · European Respiratory Journal

Belgian real-world data confirm the potential of benralizumab to induce clinical remission in patients with severe eosinophilic asthma

2024 · Lieven Dupont, Charles Pilette, et al. · European Respiratory Journal

Trends in primary outcome parameters for respiratory trials

2020 · Robert Lins, Muriel Lins, et al. · European Respiratory Journal

Sputum induction for assessment of biomarkers in early respiratory drug development

2018 · Robert Lins, Haiko Pillu, et al. · International Journal of Clinical Pharmacology and Therapeutics

P-PiXel: A 'real-life' evaluation of omalizumab use in asthmatic patients

2016 · Alain Michils, Antoine Poskin, et al. · European Respiratory Journal

Works count: 18

Citation count: 488

H-index: 6

I10-index: 6